Top 10 Regional Bank Companies To Buy Right Now

NEW YORK (TheStreet) -- The Securities and Exchange Commission on Wednesday announced that Fifth Third Bancorp (FITB) of Cincinnati and its former CFO Daniel Poston had settled charges of "improper accounting of commercial real estate loans in the midst of the financial crisis."

Fifth Third agreed to pay a $6.5 million fine, while Poston agreed to pay $100,000 and "be suspended from practicing as an accountant on behalf of any publicly traded company or other entity regulated by the SEC."

Poston had been demoted from the CFO position and named Fifth Third's "chief strategy and administrative officer in November, when Fifth Third announced its agreement to settle the charges.

The SEC accused the bank and Poston of failing to classify a pool of nonperforming commercial real estate loans as "held-for-sale" during the third quarter of 2008, even though the bank had already decided to sell the loans.  Recategorizing the loans during the third quarter of 2008 would have included a significant write down, which would have "increased Fifth Third's pretax loss for the quarter by 132 percent."

The SEC said Poston during the third quarter of 2008 was "familiar with the company's loan sale efforts, which included entering into agreements with brokers during the third quarter of 2008 to market and sell loans."  The regulatory added that "Despite understanding the relevant accounting rules, Poston failed to direct Fifth Third to classify and value the loans as required," and that the former CFO made inaccurate statements to auditors.  Poston also made inaccurate statements to Fifth Third's auditors about the company's loan classifications, and certified the company's inaccurate results for the third quarter of 2008.

Neither Fifth Third nor Poston admitted any wrongdoing.

Fifth Third's shares were down slightly during the final hour of trading Wednesday, to $19.93.

FITB data by YCharts
RELATED STORIES: Big Regional Bank Stocks Have 20% Upside for 2014, Says Credit Suisse Volcker Rule Could Trigger Big-Bank Breakup Goldman Downgrades Citi, Calls USB 'Conviction Buy' EU Slaps Big Banks With $2.3B in Rate Manipulation Fines Will Warren Buffett's Berkshire Join Fannie, Freddie Privatization Effort? Ex-Fannie CFO Howard on Fairholme's $52 Billion GSE Proposal Citigroup and Wells Have 25% Upside: Guggenheim Fed Accepts Revised Capital Plans From JPMorgan, Goldman Sachs

Best Industrial Disributor Stocks To Buy Right Now: PDL BioPharma Inc.(PDLI)

PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Advisors' Opinion:

• [By John Udovich]

  Small cap patent stocks Spherix Inc (NASDAQ: SPEX), PDL BioPharma Inc (NASDAQ: PDLI) and Endeavor IP Inc (OTCBB: ENIP) are among the�growing number of publicly traded�US entities focused on collecting and making money from various types of patents. After all, monetizing patents can lead to incredible returns. For example: Nomura analyst Rick Sherlund wrote in a research note back in November that Microsoft Corporation (NASDAQ: MSFT) is generating $2 billion per year in revenue from Android patent royalties and he�estimates that this revenue has a 95% margin. However, there are risks associated with investing in stocks that invest in patents because a bi-partisan bill called the Innovation Act (H.R. 3309) is�working its way through Congress to try and reign in the activities of so-called�"patent trolls" or rather companies that buy or license patents from others.

• [By Keith Speights]

  Mayan calendar deja vu
  Sky-high dividend yield? Low payout ratio? PDL BioPharma (NASDAQ: PDLI  ) checks these items and more off an investor's list. The company's 7.8% yield ranks as one of the highest in the entire stock market. Its payout ratio of 41% is quite attractive. Unfortunately, PDL's situation is reminiscent of the Mayan calendar hoopla from last year. The difference with PDL is that when its calendar ends, that means it's really the end.

• [By Selena Maranjian]

  PDL BioPharma (NASDAQ: PDLI  ) gained 28%, collecting royalties from a slew of medications. Its dividend yield was recently a hefty 7.6%, but investors are right to worry about its sustainability, since many of the company's revenue streams will dry up in coming years, as patents expire. Management has been seeking other revenue-generating assets and may find a new business strategy in making loans �to other medical companies.

Top 10 Regional Bank Companies To Buy Right Now: Prosensa Holding NV (RNA)

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company�� primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington�� disease. The Company�� clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company�� platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

DMD is a rare, severe muscle wasting disease that occurs in up to 1 in 3,500 male births. It is commonly diagnosed between the ages of three to five, when boys begin to show signs of impaired motor development. PRO044, the Company�� product candidate, addresses a separate sub-population of DMD patients. The Company developed PRO044 using its exon-skipping technology to generate a product candidate with the same mechanism of action that is used by drisapersen.

Advisors' Opinion:

• [By Brian Orelli]

  Ironically, phase 3 data from Sarepta's direct competitor -- GlaxoSmithKline (NYSE: GSK  ) and Prosensa's (NASDAQ: RNA  ) drisapersen -- that's due in the fourth quarter could help the FDA answer the question about whether dystrophin is an acceptable surrogate endpoint. If increases in dystrophin correlate with clinical outcomes, it would support approving eteplirsen with less data. It's not clear to me whether Glaxo and Prosensa would have to share that correlation with the FDA -- the clinical phase 3 data should be sufficient for approval -- and if it does make those calculations whether the FDA could legally use it to support the approval of another drug since NDA data is proprietary while under patent.

• [By Sean Williams]

  What: Shares of Prosensa (NASDAQ: RNA  ) , a clinical-stage developer of RNA-modulating therapeutic agents for genetic disorders, jumped as much as 50% after reporting additional clinical findings on drisapersen at the JPMorgan Healthcare Conference.

• [By Sean Williams]

  Shares of Sarepta climbed to a 52-week high of $55.61 in September shortly after an experimental rival drug, drisapersen, developed by Prosensa (NASDAQ: RNA  ) and GlaxoSmithKline (NYSE: GSK  ) , missed its primary end point by a mile in late-stage trials. However, Sarepta also tanked just weeks later after the Food and Drug Administration decided against supporting an accelerated drug approval for eteplirsen; the agency would not make the connection that increased dystrophin production led to its remarkable trial results.�Also, given the recent failure of drisapersen in a phase 3 study, the FDA felt it pertinent that Sarepta engage in a broader study. Shares ultimately dipped as low as $12.12.�

• [By John Udovich]

  Recent news surrounding small cap biotech stocks like�Xencor Inc (NASDAQ: XNCR), Prosensa Holding NV (NASDAQ: RNA),�Puma Biotechnology Inc (NYSE: PBYI),�Geron Corporation (NASDAQ: GERN)
  and TNI BioTech Inc (OTCQB: TNIB) show that while the sector and appetite for biotech�IPOs may have cooled, lottery tickets can still be found or occur in the sector. Just consider the following recent news or trends:

Top 10 Regional Bank Companies To Buy Right Now: (AMC)

AMC Entertainment Holdings, Inc., through its subsidiaries, operates as a theatrical exhibition company in the United States and internationally. As of June 30, 2011, it owned, operated, or had interests in 357 theatres and 5,098 screens in 31 states and the District of Columbia, and 4 countries outside the United States. The company was founded in 1920 and is headquartered in Kansas City, Missouri. As of August 30, 2012, AMC Entertainment Holdings, Inc. operates as a subsidiary of Dalian Wanda Group Corporation Ltd.

Advisors' Opinion:

• [By DailyFinance Staff]

  The looming Fed taper has been the talk of Wall Street for months, but it still came as a surprise to investors when it actually happened. Stocks rallied Wednesday following the Fed's decision to cut its $85 billion a month purchase of bonds by $10 billion, beginning in January. Outgoing Fed Chairman Ben Bernanke said the economy continues to "make progress." The Dow Jones industrial average (^DJI) soared 292 points on the news, its third biggest one-day gain this year. The Dow also hit a closing high, as did the Standard & Poor's 500 index (^GPSC), which gained 29 points. And the Nasdaq composite (^IXIC) rose 46 points. Consider it Bernanke's final present to the market before he retires from his position atop the Fed. Among the big blue chip winners, 3M (MMM) rose 3 percent, while Exxon Mobil (XOM), Chevron (CVX) and Goldman Sachs (GS) all rose 2 percent. But Microsoft (MSFT) was flat, reflecting across the board weakness in tech stocks. Many of the biggest players on the Nasdaq lost ground despite the overall market rally. Apple (AAPL) and Twitter (TWTR) ended lower and Tesla (TSLA) lost nearly 3 percent. Part of the reason for the tech weakness was an earnings miss and a weak forecast from Jabil Circuits (JBL), a key maker of electronics. Its shares plunged 20 percent. But homebuilders were strong following a report showing that housing starts last month rose to highest level in nearly six years. Lennar (LEN), which also posted strong earnings, jumped 6 percent. William Lyon Homes rose 4 percent, KB Homes (KBH) and Toll Brothers (TOL) each rose 3.5 percent. Ford (F) shares skidded more than 6 percent after lowering its profit forecast for next year. The company also warned that it may not meet its target for 2015 and 2016. In part, Ford blames the high expenses tied its planned launch of a record number of new vehicles next year. Finally, the movie theater chain AMC Entertainment (AMC) rose 5 percent from its $18 a share IPO price. This is exp

Top 10 Regional Bank Companies To Buy Right Now: Toshiba Corp (TOSBF)

TOSHIBA CORPORATION is a Japan-based manufacturer that operates in five business segments. The Digital Product segment manufactures and sells cellular phones, hard disc devices, optical disc devices, televisions among others. The Electronic Device segment provides general logic integrated circuits (ICs), optical semiconductors, power devices, large-scale integrated (LSI) circuits, among others. The Social Infrastructure segment manufactures and sells various generators, power distribution systems, water and sewer systems, transportation systems and station automation systems, among others. The Home Appliance segment provides refrigerators, drying machines, washing machines, cooking utensils, cleaners and lighting equipment, among others. The Others segment is involved in the provision of logistics services. In January 2014, Toshiba Corp purchased substantially all assets of OCZ Technology Group, and launched new subsidiary, OCZ Storage Solutions. Advisors' Opinion:

• [By Bruce Kennedy]

  On Monday, U.S. Attorney General Eric Holder announced indictments against five officers in China's People's Liberation Army (PLA) for ��erious cybersecurity breaches��against six American firms: Westinghouse Electric, a division of Toshiba (OTC: TOSBF) , Alcoa (NYSE: AA),�Allegheny Technologies (NYSE: ATI), U.S. Steel (NYSE: X), the United Steelworkers Union and SolarWorld (OTC: SRWRY).

Top 10 Regional Bank Companies To Buy Right Now: NV Energy Inc(NVE)

NV Energy, Inc., through its subsidiaries, generates, transmits, and distributes electric energy in Nevada. The company generates electricity from its gas, oil, and coal generating units. As of December 31, 2010, the company served approximately 830,000 electric customers primarily in Las Vegas, north Las Vegas, and Henderson and adjoining areas, including Nellis Air Force Base and the Department of Energy?s Nevada Test Site in Nye County. It also provides electricity in western, central, and northeastern Nevada comprising the cities of Reno, Sparks, Carson City, and Elko. In addition, the company distributes gas to approximately 151,000 customers in an area of approximately 800 square miles in Nevada?s Reno/Sparks area. It offers its services to residential and commercial customers, as well as to industries, including gaming/recreation, mining, warehousing/manufacturing, and other governmental entities. The company, formerly known as Sierra Pacific Resources, was founde d in 1906 and is headquartered in Las Vegas, Nevada.

Advisors' Opinion:

• [By Chris Hill]

  Shares of NV Energy (NYSE: NVE  ) rose sharply this week after Berkshire Hathaway (NYSE: BRK-A  ) (NYSE: BRK-B  ) subsidiary MidAmerican Energy announced that it was acquiring NV Energy. Berkshire Hathaway CEO Warren Buffett says NV Energy is a great fit. Is the deal a great fit for investors? In this installment of Motley Fool Money, our analysts discuss the move.

• [By Ploutos]

  U.S. Stocks

  The S&P 500 (SPY) makes a new all-time high, but closes beneath that plateau for the year. The S&P 500 eclipsed its former all-time high close of 1565 on March 28th, faster than I anticipated. With the index now ending the week above 1700 for the first time, closing below 1565 for the year seems a distant memory. Not everyone was calling for a new all-time high to be reached in 2013, and investment bank equity analysts were targeting on average high single digit annual gains at the beginning of the year. I did not expect a 19.9% return through the beginning of August, but I will take it. Grade: BThe equal-weighted S&P 500 (RSP) outperforms its capitalization-weighted alternative. The equal weighted index has produced a total return of 23.34%, besting the market capitalization-weighted S&P 500. Long-time readers know that I have long extolled the virtues of equal weighting. The lagging performance of former top holding Apple (AAPL), which has 1/14th of the weight in the equal weighted index has contributed to the outperformance of the equal weighted strategy. Grade: AThe Russell 2000 (IWM) outperforms the S&P 500 as small caps outpace large caps. The Russell 2000 has bested the S&P 500 by nearly five percent with the small cap index producing an impressive 24.8% return year-to-date. Grade: AThe shares of Bank of America (BAC) outperform J.P. Morgan (JPM) and Wells Fargo (WFC) on both an absolute and risk-adjusted basis. Bank of America has outperformed the broader market, producing a 28% total return year-to-date, but it has lagged Wells Fargo (32.1%) and J.P. Morgan (31.1%) while exhibiting higher volatility. Grade: C-The banking sector (XLF) outperforms the S&P 500. The Financial Selector Sector SPDR has produced a 27.9% year-to-date, besting the S&P 500 by roughly 8%. Grade: AHomebuilders (XHB) outperform the S&P 500, but not when adjusting for their variability of returns, which is over twice that of the broad
• [By Chuck Saletta]

  Speaking of dividends
  Of the previously existing holdings in the portfolio, two paid their dividends last week: fast-food giant McDonald's (NYSE: MCD  ) and electricity generator NV Energy (NYSE: NVE  ) . McDonald's $0.77 per share added $12.32 to the iPIG portfolio's coffers and was the company's third consecutive quarterly dividend at that rate. NV Energy's $0.19 per share handed $15.96 to the iPIG portfolio and was the second quarterly payout at that level.

Top 10 Regional Bank Companies To Buy Right Now: Alaska Communications Systems Group Inc.(ALSK)

Alaska Communications Systems Group, Inc. provides integrated communications services primarily in Alaska. The company operates in two segments, Wireline and Wireless. The Wireline segment offers voice, broadband data, internet access, long distance, and other communications products and services; local exchange network and network connectivity solutions; voice and broadband termination services to inter and intrastate carriers; and multi-protocol label switching, metro Ethernet, network access, and other information technology infrastructure hosting and management services. This segment serves business customers; multi-national corporations; municipal, state, and federal governments; residential customers; small and medium sized businesses; governmental entities; and other telecommunications carriers. The Wireless segment provides facilities-based voice, data, and other value-added services, as well as equipment sales services; and operates 14 retail stores. As of Decembe r 31, 2011, its wireless network supported approximately 118,000 connections. Alaska Communications Systems Group, Inc. was founded in 1998 and is headquartered in Anchorage, Alaska.

Advisors' Opinion:

• [By Equities Lab]

  The stocks that currently pass the stock screen in order of market cap are Frontier Communications Corp , Crown Media Holdings (CRWN), Vonage Holding (VG), MCG Capital Corp (MCGC), 1-800-FLOWERS.COM (FLWS), MTR Gaming Corporation (MNTG), Alaska Communications (ALSK), and Enzon Pharmaceuticals (ENZN).

• [By Dan Radovsky]

  For what that means to a telecom operating in the 49th state, read what Alaska Communications (NASDAQ: ALSK  ) CEO Anand Vadapalli touted during his company's second quarter 2012 earnings conference call after it got the iPhone:

Top 10 Regional Bank Companies To Buy Right Now: Resolute Forest Products Inc (RFP)

Resolute Forest Products Inc., AbitibiBowater Inc., is a global forest products company. The Company�� products include newsprint, commercial printing papers, market pulp and wood products. The Company owns or operates pulp and paper mills and wood products facilities in the United States, Canada and South Korea. On November 7, 2011, it began doing business as Resolute Forest Products. As of December 31, 2011, it owned or operated 18 pulp and paper mills and 23 wood products facilities in the United States, Canada and South Korea. The Company�� segments include newsprint, coated papers, specialty papers, market pulp and wood products. On January 14, 2011, it acquired the noncontrolling interest in Augusta Newsprint Company (ANC). In April 2012, the Company held approximately 48.8% of the outstanding shares of Fibrek Inc. In December 2012, the Company purchased Bowater Mersey Paper Company Limited. oklyn Power Corporation. Advisors' Opinion:

• [By George Putnam]

  Resolute Forest Products (RFP), formerly known as AbitibiBowater, entered into bankruptcy in early 2009, weighed down by roughly $6 billion in debt.